The Wall Street Journal: McKinsey reaches $573 million settlement with states over its work to boost OxyContin sales
Consulting giant McKinsey & Co. has reached a $573 million settlement with states over its work advising OxyContin maker Purdue Pharma LP and other drug manufacturers to aggressively market opioid painkillers, according to people familiar with the matter.
